E
Edwards Lifesciences Corporation (EW)
NYQ – Real Time Price. Currency in USD
79.73
+2.56 (3.32%)
At close: May 12, 2026, 4:00 PM EDT
79.73
0.00 (0.00%)
After-hours: May 12, 2026, 5:39 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
79.73
+2.56 (3.32%)
At close: May 12, 2026, 4:00 PM EDT
79.73
0.00 (0.00%)
After-hours: May 12, 2026, 5:39 PM EDT
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
| Name | Position |
|---|---|
| Dr. Todd Brinton FACC, M.D. | Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer |
| Mr. Andrew M. Dahl | Principal Accounting Officer, Senior VP & Corporate Controller |
| Mr. Bernard J. Zovighian | CEO & Director |
| Mr. Daveen Chopra | Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies |
| Mr. Donald E. Bobo Jr. | Corporate Vice President of Strategy & Corporate Development |
| Mr. Joseph Nuzzolese |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | 8-K | ew-20260507.htm |
| 2026-05-06 | 10-Q | ew-20260331.htm |
| 2026-05-04 | 8-K | ew-20260502.htm |
| 2026-04-23 | 8-K | ew-20260423.htm |
| 2026-03-26 | DEFA14A | ewnaa26.htm |
| 2026-02-25 | 10-K | ew-20251231.htm |
| 2026-02-10 | 8-K | ew-20260210.htm |
| 2026-01-12 | 8-K | ew-20260109.htm |
| 2025-11-05 | 10-Q | ew-20250930.htm |
| 2025-10-30 | 8-K | d50813d8k.htm |
| Corporate Vice President of Global Operations & Quality |
| Mr. Mark D. Peterson | Corporate VP & General Counsel |
| Mr. Scott B. Ullem | Corporate VP & CFO |
| Mr. Snehashish Sarkar | Senior VP and Chief Information & Digital Officer |
| Ms. Annette Maria Bruls | Corporate Vice President of EMEA, Canada, & Latin America |